Amyloid-reoriented enzyme catalysis
Enzyme catalysis is essential for molecular transformations. Here, we make use of amyloid, a fibrillar aggregate formed by stacking peptides with β-sheet, which offers unique selectivity in enzymatic reactions. Azo-stilbene derivative (ASB), the amyloid-recognition motif, is incorporated into the substrate, which allows the amyloid consisting of Bz-Phe-Phe-Ala-Ala-Leu-Leu-NH<sub>2</sub> (BL7) to shield the substrates from the approaching enzyme. X-ray crystallographic analysis and structure-shielding effect relationship studies of BL7 reveal that the benzene rings present in the N-terminal benzoyl group and Phe1 side chain are particularly important for the shielding effect on the substrate. The finding results in a selective transformation system in which the reactive site close to ASB is protected by amyloid, while a site far from ASB is converted by the enzymes (trypsin, protein arginine deiminase [PAD], and Staphylococcus aureus V-8 Protease [Glu-C]). Further, the amyloid-shielded enzyme catalysis is compatible with an intact peptide, as the side chain of Tyr can be converted to the amyloid-recognizing motif. The enzymatic reactions combining amyloid provide unique selectivity for molecular transformation which may be used in diverse fields, including in synthetic chemistry.
Authors
- Taka Sawazaki (ORCID: https://orcid.org/0000-0001-5650-998X)
- Youhei Sohma (ORCID: https://orcid.org/0000-0002-1154-3903)
- Fabrício Murai (ORCID: https://orcid.org/0000-0003-4487-6381)
- Daisuke Sasaki (ORCID: https://orcid.org/0000-0002-2224-1900)
- Kenji Yamamoto (ORCID: https://orcid.org/0000-0001-8430-1860)
Institutions
- Wakayama Medical University (JP)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1038/s41467-025-58536-5
- Primary Topic
- Chemical Synthesis and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Hoansha Foundation
- Wakayama Medical University
- Astellas Pharma
- Astellas Foundation for Research on Metabolic Disorders
- Japan Society for the Promotion of Science